Chemoinformaics analysis of 2,5-Dimethyldodecane
| Molecular Weight | 198.394 | nRot | 9 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 0 |
| Exact Molecular Weight | 198.235 | nRing | 0 |
| Solubility: LogS | -6.762 | nHRing | 0 |
| Solubility: LogP | 6.985 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 43.3838 |
| nHD | 0 | BPOL | 30.0962 |
| QED | 0.434 |
| Synth | 2.329 |
| Natural Product Likeliness | 1.026 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.407 |
| MDCK | 0.00000998 |
| BBB | 0.341 |
| PPB | 0.978359 |
| VDSS | 2.967 |
| FU | 0.0229773 |
| CYP1A2-inh | 0.494 |
| CYP1A2-sub | 0.217 |
| CYP2c19-inh | 0.472 |
| CYP2c19-sub | 0.728 |
| CYP2c9-inh | 0.402 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.043 |
| CYP3a4-inh | 0.138 |
| CYP3a4-sub | 0.115 |
| CL | 6.184 |
| T12 | 0.087 |
| hERG | 0.056 |
| Ames | 0.005 |
| ROA | 0.03 |
| SkinSen | 0.901 |
| Carcinogencity | 0.043 |
| EI | 0.967 |
| Respiratory | 0.291 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.735477 |